ataxia telangiectasia Rad3 inhibitors (Merck Serono)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameataxia telangiectasia Rad3 inhibitors (Merck Serono)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine-protein kinase ATR inhibitors
TargetsSerine-protein kinase ATR
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGeorgiaSpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentro Nacional De Investigaciones Oncologicas
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono SaCentro Nacional De Investigaciones Oncologicas
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A